Tafluprost
- Product NDC
- 65302-062
- 11-digit product format
- 653020062
- Labeler code
- 65302
- Product ID
- 65302-062_f05e2b3e-be98-5187-e053-2a95a90a1067
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tafluprost
- Dosage form
- SOLUTION
- Route
- OPHTHALMIC
- Labeler
- The Ritedose Corporation
- Application
- ANDA209040
- Marketing category
- ANDA
- Marketing start
- 2022-12-05
- Marketing end
- 0000-00-00
- Substance
- TAFLUPROST
- Active strength
- 0 mg/.3mL
- Pharmacologic classes
- Increased Prostaglandin Activity [PE], Prostaglandin Analog [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65302-062-05 | 65302006205 | 6 POUCH in 1 CARTON (65302-062-05) > 5 AMPULE in 1 POUCH > .3 mL in 1 AMPULE | 6 pouch | 2022-12-05 | 0000-00-00 | No | No | Current |